Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
17.80
-0.69 (-3.73%)
Mar 23, 2026, 4:00 PM EDT - Market closed
Apollomics Market Cap
Apollomics has a market cap or net worth of $38.22 million as of March 24, 2026. Its market cap has increased by 299.31% in one year.
Market Cap
38.22M
Enterprise Value
36.86M
1-Year Change
299.31%
Ranking
Category
Stock Price
$17.80
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $38.22M, a decrease of -70.51%. That is a compound annual growth rate of -24.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 38.22M | -4.75% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 40.68M |
| Werewolf Therapeutics | 39.97M |
| Atara Biotherapeutics | 39.62M |
| Estrella Immunopharma | 38.52M |
| CervoMed | 37.22M |
| NextCure | 37.06M |
| LeonaBio | 36.95M |
| Veru Inc. | 36.92M |